Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02003352 · ClinicalTrials.gov registry record · NA
Study of PTSD in Military Veterans Who Have Suffered Traumatic Brain Injuries
A NA study of PTSD and TBI, sponsored by Carrick Institute for Graduate Studies.
- Completed
- Registry status
- NA
- Development phase
- 98
- Enrollment target
- 1
- Study location
NCT02003352: Completed NA study of PTSD and TBI, sponsored by Carrick Institute for Graduate Studies.
NCT02003352 is a NA study of PTSD and TBI that has completed, run by Carrick Institute for Graduate Studies. The registered enrollment target is 98 participants, below the 301-participant average among 154 other PTSD trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02003352, a NA study of PTSD and TBI, has completed, sponsored by Carrick Institute for Graduate Studies.
- COMPLETED
- Registry status
- NA
- Development phase
- 98 participants
- Enrollment target
- 1
- Study location
Study Summary
Treatment for veterans who have had a traumatic brain injury (TBI) and who are suffering from post traumatic stress syndrome (PTSD) is varied with varied outcomes. Investigators will study PTSD treatment in military Veterans who have suffered traumatic brain injuries. Investigators will use 1 independent specialty treatment centers that utilize a specific novel methodology of PTSD treatments and study the clinical outcomes of veterans who have suffered a TBI with associated post-concussive symptoms and other comorbidities such as PTSD. Investigators hypothesize that the treatment of PTSD will have a significant outcome with neurological physical and vestibular rehabilitation when compared to psychological or psychiatric therapy. This study will use gold standard measurement scales and compare changes in the scales after treatment to evaluate the treatments.
Primary Outcome
The CAPS is the gold standard in PTSD assessment and is a 30-item structured interview.For each symptom, standardized questions and probes are provided. Administration requires identification of an index traumatic event to serve as the basis for symptom inquiry. The full interview takes 45-60 minutes to administer.CAPS symptom severity ratings are based on symptom frequency and intensity (except for amnesia and diminished interest which are based on amount and intensity). Higher scores represent
Interventions
- PROCEDURE Functional Neurological Rehabilitation
Study Locations (1)
Texas
- Carrick Brain Centers - Irving
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 98 participants |
| Start Date | 2014-03 |
| Est. Completion | 2014-09 |
| Phase | NA |
What the finished NCT02003352 record still lists
NCT02003352 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 98 participants, a relatively small participant target, below the 301-participant average among 154 other PTSD trials with a reported enrollment target (67% lower).
The record links to 2 conditions, with PTSD appearing as the primary indexed condition, and to 1 intervention - of which Functional Neurological Rehabilitation is the first listed.
NCT02003352 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT02003352 about?
NCT02003352 is a clinical study titled "Study of PTSD in Military Veterans Who Have Suffered Traumatic Brain Injuries". Treatment for veterans who have had a traumatic brain injury (TBI) and who are suffering from post traumatic stress syndrome (PTSD) is varied with varied outcomes. Investigators will study PTSD treatment in military Veterans who have suffered traumatic brain injuries. Investigators will use 1 indepe...
What is the current status of trial NCT02003352?
This trial is currently completed. It is a NA study. The enrollment target is 98 participants. The study started on 2014-03. Estimated completion is 2014-09.
What conditions does trial NCT02003352 study?
This clinical trial studies the following conditions: PTSD, TBI.
What interventions are being tested in trial NCT02003352?
The interventions under investigation include: Functional Neurological Rehabilitation (PROCEDURE).
Who is sponsoring clinical trial NCT02003352?
This trial is sponsored by Carrick Institute for Graduate Studies, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02003352 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for PTSD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02003352's enrollment target sits among peer trials
98 67th of 154 higher than 88 of 154 other PTSD trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other PTSD trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
Treatments for Insomnia in Veterans With PTSD
RECRUITING · NA
-
REstoring Mental Health Through COmmUnity-based Psychological Services in New York City
RECRUITING · NA
-
Recovery Through Inhibitory Learning, Self-Efficacy Building, Problem Solving, and Community Building
RECRUITING · NA
-
Project Safe Guard-Trauma
RECRUITING · NA
-
Neuromodulation of the Fear Extinction Circuit Using Temporally and Anatomically Specific TMS in Humans
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02926729 · 98 participants · NA
Real-Time Assessment Of Breast Cancer Lumpectomy Specimen Margins With Nonlinear Microscopy
- NCT03382977 · 98 participants · Phase 1
Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects
- NCT04577014 · 98 participants · Phase 1
Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma
- NCT04817618 · 98 participants · Phase 3
Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia